Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shelton A. Viola"'
Autor:
Nathalie Javidi-Sharifi, Jacqueline Martinez, Isabel English, Sunil K Joshi, Renata Scopim-Ribeiro, Shelton K Viola, David K Edwards V, Anupriya Agarwal, Claudia Lopez, Danielle Jorgens, Jeffrey W Tyner, Brian J Druker, Elie Traer
Publikováno v:
eLife, Vol 8 (2019)
Externí odkaz:
https://doaj.org/article/1676b10ade3b455f8c9d2a4bf4ea83a7
Autor:
Nathalie Javidi-Sharifi, Jacqueline Martinez, Isabel English, Sunil K Joshi, Renata Scopim-Ribeiro, Shelton K Viola, David K Edwards V, Anupriya Agarwal, Claudia Lopez, Danielle Jorgens, Jeffrey W Tyner, Brian J Druker, Elie Traer
Publikováno v:
eLife, Vol 8 (2019)
Protective signaling from the leukemia microenvironment leads to leukemia cell persistence, development of resistance, and disease relapse. Here, we demonstrate that fibroblast growth factor 2 (FGF2) from bone marrow stromal cells is secreted in exos
Externí odkaz:
https://doaj.org/article/1c66ad09cee24491a3ce0b7b0754affd
Autor:
R. Spencer Tong, Robert B. Gerbing, Todd A. Alonzo, Jeffrey W. Taub, Jim Wang, Lisa Eidenschink Brodersen, Reuven J. Schore, Maureen M. O'Brien, Amy Heerema-McKenney, Jason N. Berman, Shelton A Viola, Michael R. Loken, E. Anders Kolb, Betsy A. Hirsch, Alan S. Gamis, Karen M. Chisholm, Susana C. Raimondi, Nobuko Hijiya, Amy Beckman, Johann Hitzler, Todd E. Druley
Publikováno v:
Blood. 138:2337-2346
Myeloid leukemia in children with Down syndrome (ML-DS) is associated with young age and somatic GATA1 mutations. Because of high event-free survival (EFS) and hypersensitivity of the leukemic blasts to chemotherapy, the prior Children’s Oncology G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e09340fb26ba3d69a872971ec1b2e4b9
https://doi.org/10.1182/blood.2021012206
https://doi.org/10.1182/blood.2021012206
Autor:
Scott W. Penney, Jenny H. Jung, Aaron J. Ballantyne, Dina S. Parekh, David A. Klein, Shelton A. Viola
Publikováno v:
Journal of pediatric hematology/oncology. 44(5)
Medical affirmation, including gender-affirming hormones, is an essential component in the treatment of many transgender and gender-diverse youth. The risk of venous thromboembolism (VTE) during testosterone therapy for gender-affirming care is not f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a29d0a462317a9c9122feee6692e0e
https://pubmed.ncbi.nlm.nih.gov/35293883
https://pubmed.ncbi.nlm.nih.gov/35293883
Autor:
Chantel Aftab, Shelton A Viola
Publikováno v:
Pediatric bloodcancerREFERENCES. 66(11)
Bone marrow-derived mesenchymal stem and stromal cells (BM-MSCs) protect malignant cells from chemotherapy and are important potential therapeutic targets. Isolating primary BM-MSCs for research traditionally requires the sacrifice of valuable cell p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b471d2d153f9c031b5b8c462386509
https://pubmed.ncbi.nlm.nih.gov/31390164
https://pubmed.ncbi.nlm.nih.gov/31390164
Autor:
Danielle M. Jorgens, Jacqueline Martinez, Claudia S. López, Anupriya Agarwal, David K. Edwards, Isabel English, Renata Scopim-Ribeiro, Shelton K. Viola, Nathalie Javidi-Sharifi, Brian J. Druker, Elie Traer, Sunil K. Joshi, Jeffrey W. Tyner
Publikováno v:
eLife, Vol 8 (2019)
eLife
eLife
Protective signaling from the leukemia microenvironment leads to leukemia cell persistence, development of resistance, and disease relapse. Here, we demonstrate that fibroblast growth factor 2 (FGF2) from bone marrow stromal cells is secreted in exos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b4b4ec38d2e9ef10d80b7edc4eddd7
https://elifesciences.org/articles/47174
https://elifesciences.org/articles/47174
Autor:
David K. Edwards, Brian J. Druker, Jacqueline Martinez, Isabel English, Danielle M. Jorgens, Shelton K. Viola, Elie Traer, Jeffrey W. Tyner, Anupriya Agarwal, Nathalie Javidi-Sharifi, Renata Scopim-Ribeiro, Sunil K. Joshi, Claudia S. López
Publikováno v:
eLife, Vol 8 (2019)
eLife
eLife
Protective signaling from the leukemia microenvironment leads to leukemia cell persistence, development of resistance, and disease relapse. Here, we demonstrate that fibroblast growth factor 2 (FGF2) from bone marrow stromal cells is secreted in exos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b92c9427d4ac6d218c6e6231f49be0
https://elifesciences.org/articles/40033
https://elifesciences.org/articles/40033
Autor:
Nathalie Javidi-Sharifi, Jacqueline Martinez, Isabel English, Sunil K Joshi, Renata Scopim-Ribeiro, Shelton K Viola, David K Edwards, Anupriya Agarwal, Claudia Lopez, Danielle Jorgens, Jeffrey W Tyner, Brian J Druker, Elie Traer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44894e74328e8a1395e4e2387cebc6f4
https://doi.org/10.7554/elife.40033.029
https://doi.org/10.7554/elife.40033.029
